Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ChronoScale Holdings Corp files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
FY2025
FY2026
Revenue
11.3
13.9
8.88
11.2
12.9
18.3
17.9
84.4
12.8
71.6
Cost of revenue
7.02
7.15
3.81
4.5
6.7
9.2
8.41
115
5.95
88.7
Gross profit
4.31
6.76
5.07
6.75
6.21
9.08
9.51
-30.9
6.85
-17.1
Research and development
5.85
4.6
2.47
2.55
3.63
5.03
3.87
3.03
Selling, general and administrative
24.8
19.8
Selling and marketing
13.8
11.4
7.75
7.31
7.16
8.47
7.31
7.15
General and administrative
11.7
7.41
7.7
10.7
11
10.7
8.79
9.99
Operating expenses
31.3
23.4
18.4
20.6
21.8
24.2
20
20.2
Operating income
-27
-16.6
-13.3
-13.8
-15.6
-15.1
-10.5
-55.3
-13.3
-37.5
Interest expense
0.6
0.38
0.14
0.11
0.16
0.3
0.27
0.31
Other non-operating income
0.04
4.51
-2.53
4.06
0.48
-0.09
-0.87
0
1.63
-0.01
Pre-tax income
-27
-12.1
-15.8
-9.76
-15.1
-15.2
-11.3
-72.7
-11.7
-49.3
Income tax
0
0
0
Income from continuing operations
-72.7
-49.3
Net income
-27
-12.1
-15.8
-9.76
-15.1
-15.2
-11.3
-72.7
-11.7
-50.3
EBITDA
-26
-15.9
-12.7
-12.8
-14.7
-13.4
-8.85
25.3
-11.8
22.8
EPS, basic
-6.55
-2.53
-2.21
-0.80
-1.16
-1.10
-8.43
-0.53
-4.91
-0.36
EPS, diluted
-6.55
-2.53
-2.21
-0.88
-1.16
-1.10
-8.43
-0.53
-4.91
-0.36
Shares, basic (weighted)
4.11
4.79
7.16
12.2
13
13.9
1.34
138
2.43
139
Shares, diluted (weighted)
4.11
4.79
7.16
12.3
13
13.9
20.2
138
2.43
139
Balance sheet
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
FY2025
FY2026
Cash and equivalents
7.66
10.9
12.9
40.4
20.5
8.64
4.49
2.4
1.17
9.66
Receivables
3.66
5.21
3.22
4.66
4.63
5.65
7.24
3.79
7.31
12.5
Inventory
3.37
2.49
1.98
2.24
5.19
5.05
4.57
4.82
Other current assets
0.28
0.24
0.36
0.49
0.7
0.88
0.54
0.22
0.75
2.2
Total current assets
15
18.8
18.4
47.8
31
20.2
18.8
6.41
14
44.2
Property, plant and equipment
2.37
1.66
1.17
0.99
2.68
2.02
1.58
10.9
1.29
32.1
Lease right-of-use assets
0
1.08
0.69
0.22
1.31
0.98
0.79
91.4
0.53
72
Goodwill
0.19
0.19
0
0
0.43
0.43
0.43
0
0.43
54.5
Intangible assets
0
5.22
4.89
4.58
3.5
Other non-current assets
0.13
0.18
0.32
0.16
0.23
0.39
0.43
0
0.31
0.52
Total assets
17.7
21.9
20.6
49.2
40.9
28.9
26.7
304
20.1
326
Accounts payable
3.16
1.9
1.5
3.11
3.15
1.85
1.55
3.96
1.43
9.05
Accrued liabilities
3.49
1.68
1.43
2.3
2.28
2.66
2.35
0.57
1.78
3.74
Deferred revenue
1.1
1.49
1.5
1.22
1.12
1.99
1.96
3.59
1.73
0
Short-term debt
2.33
2.33
0
0
0
3.37
Total current liabilities
10.1
7.83
4.97
6.86
9.2
8.12
7.54
158
8.64
86.9
Long-term debt
2.65
0.41
1.99
1.99
3.77
4.83
3.85
12
0.8
0.47
Lease liabilities
0
0.71
0.23
0
1.09
0.72
0.45
58.4
0.15
40.3
Other non-current liabilities
0.12
0.07
0.04
0.07
0.14
0.11
0.18
0.09
Total liabilities
14.9
15.1
16.2
11.9
15.5
16.3
13.9
228
11.1
144
Total debt
4.98
2.74
1.99
1.99
12
3.84
Paid-in capital
174
190
204
246
249
252
262
225
272
379
Retained earnings
-171
-183
-199
-209
-224
-239
-250
-149
-262
-199
Other comprehensive income
-0.09
0.05
-0.85
-0.02
0.56
0.16
0.96
-0.69
Shareholders' equity
2.73
6.8
4.43
37.2
25.4
12.6
12.7
76.2
9.03
180
Total equity
2.73
6.8
4.43
37.2
25.4
12.6
12.7
76.2
9.03
180
Total liabilities and equity
17.7
21.9
20.6
49.2
40.9
28.9
26.7
304
20.1
326
Shares outstanding
4.23
5.8
8.35
12.7
13.2
14.8
1.48
138
3.56
145
Cash flow statement
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2026
FY2025
FY2026
Net income
-27
-12.1
-15.8
-9.76
-15.1
-15.2
-11.3
-72.7
-11.7
-50.3
Depreciation and amortization
1.01
0.69
0.62
1.02
0.89
1.7
1.61
80.7
1.57
60.3
Stock-based compensation
2.87
2.26
2.41
2.33
2.55
1.86
1.37
-1.46
1.47
1.3
Change in receivables
-0.85
-1.6
1.75
-1.62
-0.07
-1.21
-1.97
-3.79
0.45
-8.54
Change in inventory
-1.66
0.96
0.38
-0.75
-1.4
0.23
0.26
-0.28
Change in payables
0.75
-1.23
-0.4
1.61
-0.1
-1.31
-0.29
-9.01
-0.14
4.57
Cash from operations
-22.2
-15.8
-8.76
-11.2
-14.7
-12.1
-9.85
-7.22
-11.8
39.1
Capital expenditures
-0.13
-0.06
0
-0.06
-0.19
-0.16
-0.04
-1.38
-0.19
-26.9
Acquisitions
0
-5
0
Cash from investing
-0.13
-0.06
0
-0.06
-5.18
-0.16
-0.04
-1.38
-0.19
-25.2
Debt issued
0
3.08
0
Stock issued
4.45
21.2
7.08
37.3
0
0.66
9.02
0
4.1
15.8
Cash from financing
2.27
19
10.7
38.7
0
0.35
7.77
11
6.63
-6.63
Exchange rate effect
-0.14
0.01
0.04
0.05
-0.02
-0.02
-0.03
0.04
Net change in cash
-20.2
3.22
1.99
27.5
-19.9
-11.9
-2.15
2.4
-5.32
7.27
Free cash flow
-22.3
-15.8
-8.76
-11.2
-14.9
-12.2
-9.88
-8.6
-12
12.2
Interest paid
0.02
0.02
0.01
0
0.13
0.19
0.18
17.3
0.12
9.53
Income taxes paid
0.46
0.31
0.11
0.1
0.01
0.05
0.01
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $19.85 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-23.9%
Gross profit / revenue.
Operating margin
-52.4%
Operating income / revenue.
EBITDA margin
31.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-68.9%
Pre-tax income / revenue.
Net margin
-70.3%
Net income / revenue.
FCF margin
17.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
54.6%
Cash from operations / revenue.
Return on equity (ROE)
-28.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-15.4%
Net income / average total assets.
Return on invested capital (ROIC)
-17.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
27.7%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
1.8%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
37.5%
Capital expenditures / revenue.
D&A / revenue
84.3%
Depreciation and amortization / revenue.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.51x
Current assets / current liabilities.
Quick ratio
0.26x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.11x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.02x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
1.2%
Total debt / total assets.
Liabilities / assets
44.1%
Total liabilities / total assets.
Net debt
-$5.8M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-0.25x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.36
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.36
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.52
Revenue / diluted weighted shares.
FCF per share
$0.09
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.28
Cash from operations / diluted weighted shares.
Book value per share
$1.24
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
40.3x
Market cap / revenue.
P/B
16.0x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
23.0x
Market cap / tangible book value, when positive.
P/FCF
236x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
73.8x
Market cap / cash from operations, when positive.
EV/Sales
40.2x
Enterprise value / revenue.
EV/EBITDA
126x
Enterprise value / EBITDA, when both are positive.
EV/FCF
236x
Enterprise value / free cash flow, when both are positive.
FCF yield
0.4%
Free cash flow / market cap.
Earnings yield
-1.7%
Net income / market cap (the inverse of P/E).
What was ChronoScale Holdings Corp's revenue in fiscal 2026?
ChronoScale Holdings Corp reported revenue of $71.6M for fiscal 2026, 459.4% higher than the year before.
Was ChronoScale Holdings Corp profitable in fiscal 2026?
No. It reported a net loss of $50.3M.
How much free cash flow did ChronoScale Holdings Corp generate in fiscal 2026?
Cash from operations of $39.1M minus capital expenditures of $26.9M left free cash flow of $12.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.